Submitted by Anonymous (not verified) on 28 November 2023 - 12:40
Human medicines European public assessment report (EPAR): Pravafenix, fenofibrate,pravastatin, Dyslipidemias, Date of authorisation: 14/04/2011, Revision: 8, Status: Authorised
Source:
